Stay updated on PF-04958242 in Schizophrenia CIAS Clinical Trial
Sign up to get notified when there's something new on the PF-04958242 in Schizophrenia CIAS Clinical Trial page.

Latest updates to the PF-04958242 in Schizophrenia CIAS Clinical Trial page
- CheckyesterdayChange DetectedLocations section consolidated into a single 'Locations' listing the participating states (CA, GA, IL, LA, MD, NJ, TN, TX, WA), replacing individual state subsections. The HHS Vulnerability Disclosure link was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. It appears to be a maintenance change with no modification to the study content, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding status notice at the top of the page has been removed. It previously stated that information may not be up to date during funding lapses and directed users to opm.gov for updates.SummaryDifference0.4%

- Check51 days agoChange DetectedThe study record indicates termination of the trial on Sept 22, 2016 due to internal portfolio prioritization, with a note that this was not due to safety concerns; enrollment and completion details are updated accordingly.SummaryDifference0.3%

- Check80 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

- Check87 days agoChange Detected- Added Revision: v3.1.0 to indicate a new version. - Removed several MedlinePlus topics: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and Revision: v3.0.2. - Overall, the page now signals a new version while stripping specific topic entries related to drug safety/quality.SummaryDifference0.4%

Stay in the know with updates to PF-04958242 in Schizophrenia CIAS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-04958242 in Schizophrenia CIAS Clinical Trial page.